Biotech Deal Guides
In-depth resources for licensing professionals and BD teams
How to Value a Biotech Deal
A complete step-by-step guide to valuing biopharma licensing deals using comparable transactions, rNPV analysis, and Monte Carlo simulation.
How to Negotiate Pharma Licensing Royalty Rates
Data-backed strategies for structuring and negotiating royalty rates in biopharma licensing deals, with benchmarks from 3,000+ transactions.
Biotech Licensing Deal Structure: Upfront, Milestones & Royalties
Comprehensive breakdown of the three pillars of biopharma licensing economics, with benchmark data and structuring strategies for each component.
Risk-Adjusted NPV (rNPV) for Biotech Valuation
Master the industry-standard rNPV methodology for valuing biotech assets, from phase transition probabilities to Monte Carlo enhancement.
Pharma M&A vs. Licensing: When to Acquire vs. License
Strategic framework for choosing between M&A and licensing in biopharma, with case studies and decision criteria for BD professionals.
Ready to Benchmark Your Deal?
Use our calculator to model deal terms based on real market data.
Try the Calculator